The IHC results revealed that the expression levels of FABP3 and CPT-1α were significantly upregulated in the heart tissues of the obese T2DM patients compared with those of the healthy individuals, but the expression of these proteins was not upregulated in the non-obese T2DM patients (Figure 8G and H). This evidence concerns the gene CPT1A and type 2 diabetes mellitus.